Whipple's disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 21: Line 21:


{| class="wikitable"
{| class="wikitable"
! rowspan="3" |Cause
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause
! rowspan="3" |Peak age of onset
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Peak age of onset
! colspan="6" |History
! colspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" |History
! rowspan="3" |Physical exam
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Physical exam
! colspan="4" rowspan="2" |Lab findings
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Lab findings
! rowspan="3" |Additional finding
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Additional finding
! rowspan="3" |Cause/Pathogenesis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause/Pathogenesis
! rowspan="3" |Gold standard diagnosis
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis
|-
|-
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Diarrhea
! colspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Diarrhea
| rowspan="2" |Fever
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Fever
| rowspan="2" |Weight loss
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Weight loss
| rowspan="2" |Abdominal pain
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Abdominal pain
! rowspan="2" |Arthralgia
! rowspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Arthralgia
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" |Watery
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Watery
! align="center" style="background:#4479BA; color: #FFFFFF;" |Fatty
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Fatty
!WBC
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |WBC
!Hgb
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Hgb
!Plt
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Plt
!Other lab findings
! align="center" style="background:#7d7d7d; color: #FFFFFF;" |Other lab findings
|-
|-
! align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |Whipple's disease
====== Whipple's disease ======
| align="center" style="background:#F5F5F5;" | 50th
| align="center" style="background:#FFFAFA;" | 50th
| align="center" | +/-
| align="center" | +/-
| align="center" | +
| align="center" | +
Line 75: Line 74:
* [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing  
* [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing  
|-
|-
| align="center" style="background:#DCDCDC;" |
! align="center" style="background:#DCDCDC;" |[[Celiac disease]]
====== [[Celiac disease]] ======
| align="center" style="background:#F5F5F5;" | Childhood
| align="center" style="background:#FFFAFA;" | Childhood


Adult
Adult
Line 115: Line 113:
|-
|-
! align="center" style="background:#DCDCDC;" |Grain allergy
! align="center" style="background:#DCDCDC;" |Grain allergy
| align="center" style="background:#FFFAFA;" |Childhood
| align="center" style="background:#F5F5F5;" |Childhood
| +
| +
| -
| -
Line 139: Line 137:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]]
| align="center" style="background:#FFFAFA;" | Infancy and childhood
| align="center" style="background:#F5F5F5;" | Infancy and childhood
| align="center" | -
| align="center" | -
| align="center" | +
| align="center" | +
Line 168: Line 166:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
| align="center" style="background:#FFFAFA;" | Adult
| align="center" style="background:#F5F5F5;" | Adult
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 196: Line 194:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]]
| align="center" style="background:#FFFAFA;" | Young adults
| align="center" style="background:#F5F5F5;" | Young adults
(20th)
(20th)
| align="center" | +
| align="center" | +
Line 227: Line 225:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]]
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]]
| align="center" style="background:#FFFAFA;" | After childhood
| align="center" style="background:#F5F5F5;" | After childhood
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 254: Line 252:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]]
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]]
| align="center" style="background:#FFFAFA;" | Any age
| align="center" style="background:#F5F5F5;" | Any age
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 285: Line 283:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]]
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]]
| align="center" style="background:#FFFAFA;" | Between 30 and 50
| align="center" style="background:#F5F5F5;" | Between 30 and 50
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 311: Line 309:
|-
|-
! align="center" style="background:#DCDCDC;" |[[VIPoma]]
! align="center" style="background:#DCDCDC;" |[[VIPoma]]
| align="center" style="background:#FFFAFA;" | Between 30 and 50
| align="center" style="background:#F5F5F5;" | Between 30 and 50
| +
| +
| -
| -
Line 344: Line 342:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]])
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]])
| align="center" style="background:#FFFAFA;" | Between the ages of 20 and 50
| align="center" style="background:#F5F5F5;" | Between the ages of 20 and 50
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 367: Line 365:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]]
| align="center" style="background:#FFFAFA;" | Any age
| align="center" style="background:#F5F5F5;" | Any age
| align="center" | -
| align="center" | -
| align="center" | +
| align="center" | +
Line 396: Line 394:
|-
|-
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES)
| align="center" style="background:#FFFAFA;" | Infancy
| align="center" style="background:#F5F5F5;" | Infancy
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 422: Line 420:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] 
| align="center" style="background:#FFFAFA;" | 30th
| align="center" style="background:#F5F5F5;" | 30th
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -
Line 448: Line 446:
|-
|-
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption
| align="center" style="background:#FFFAFA;" | Childhood Adolescents
| align="center" style="background:#F5F5F5;" | Childhood Adolescents
| align="center" | +
| align="center" | +
| align="center" | +/-
| align="center" | +/-
Line 471: Line 469:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]]
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]]
| align="center" style="background:#FFFAFA;" | Infancy
| align="center" style="background:#F5F5F5;" | Infancy
| align="center" | -
| align="center" | -
| align="center" | +
| align="center" | +
Line 500: Line 498:
|-
|-
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]]
| align="center" style="background:#FFFAFA;" | 60th
| align="center" style="background:#F5F5F5;" | 60th
| align="center" | +
| align="center" | +
| align="center" | -
| align="center" | -

Revision as of 14:54, 30 October 2017

Whipple's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Whipple's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Whipple's disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Whipple's disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Whipple's disease differential diagnosis

CDC on Whipple's disease differential diagnosis

Whipple's disease differential diagnosis in the news

Blogs on Whipple's disease differential diagnosis

Directions to Hospitals Treating Whipple's disease

Risk calculators and risk factors for Whipple's disease differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, multi system involvement, such as Celiac disease, systemic infections, and inflamatory bowel disease.

Differentiating Whipple's disease from other Diseases

Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, joins involvement, and neurologic symptoms.

The following diseases have presentations similar to that of Whipple's disease.

The table below summarizes the diseases that cause malabsorption, diarrhea and abdominal pain.[1][2][3][4][5][6][7][8]

Abbreviations: WBC: White blood cells; Plt: Platelets; Hgb: Hemoglobin ; IgE: Immunoglobulin E ; IgA: Immunoglobulin A ;

Cause Peak age of onset History Physical exam Lab findings Additional finding Cause/Pathogenesis Gold standard diagnosis
Diarrhea Fever Weight loss Abdominal pain Arthralgia
Watery Fatty WBC Hgb Plt Other lab findings
Whipple's disease 50th +/- + + + + +
Celiac disease Childhood

Adult

+/- +/- - + + + - -
  • IgA endomysial antibody
  • Anti-tissue transglutaminase antibody
  • Anti-gliadin antibody
  • IgA endomysial antibody
  • IgA tissue transglutaminase antibody
Grain allergy Childhood + - - + + -
Cystic fibrosis Infancy and childhood - + + +
  • Positive DNA analysis for CFTR multimutation method
  • Evaluated nasal transepithelial potential difference (NPD)
Lactose intolerance Adult + - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Crohns disease Young adults

(20th)

+ - + +
  • Abnormal immune response to self antigens
Laxative overuse After childhood + - +/- +/- -
Hyperthyroidism Any age + - + +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
Irritable bowel syndrome Between 30 and 50 + - - + -
VIPoma Between 30 and 50 + - + +/-
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Gastrinoma (Zollinger-Ellison syndrome) Between the ages of 20 and 50 + - + +
  • Elevated basal or stimulated serum gastrin more than 1000 pg/mL
Lactose intolerance Any age - + + +/-
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) Infancy + - +/- + Stool examination:
  • Triggered by cow milk protein
  • Profuse, repetitive vomiting
  • Oral food challenge (OFC)
Eosinophilic gastroenteritis  30th + - +/- +
Primary bile acid malabsorption Childhood Adolescents + +/- + +/- -
Abetalipoproteinemia Infancy - + + +
Microscopic colitis 60th + - + +

References

  1. Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  2. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  3. BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.
  4. SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.
  5. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  6. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  7. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
  8. RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.

Template:WH Template:WS